Jing Jin

机构：The University of Sydney, Sun Yat-sen University, Chinese Academy of Medical Sciences & Peking Union Medical College, National Medical Products Administration, Peking Union Medical College Hospital, National Cancer Center, Shanghai Institute of Materia Medica, Yangzhou University · ORCID：0000-0002-6645-5214

发表论文 191 篇 · 总被引 6430 次 · h-index 37

代表论文

• A deep neural network predictor to predict the sensitivity of neoadjuvant chemoradiotherapy in locally advanced rectal cancer (2024 · Cancer Letters · 被引 20)
• The prognostic value of tumour-infiltrating lymphocytes, programmed cell death protein-1 and programmed cell death ligand-1 in Stage I–III triple-negative breast cancer (2023 · British Journal of Cancer · 被引 10)
• The short-term efficacy and safety of induction chemotherapy combined with PD-1 inhibitor or anti-EGFR in locoregionally advanced nasopharyngeal carcinoma (2023 · Frontiers in Oncology · 被引 9)
• A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma (2024 · Scientific Reports · 被引 8)
• Correlation between AI-based CT organ features and normal lung dose in adjuvant radiotherapy following breast-conserving surgery: a multicenter prospective study (2023 · BMC Cancer · 被引 8)
• Study on the Differentiation of Infiltrating Breast Cancer Molecular Subtypes Based on Ultrasound Radiomics (2025 · Clinical Breast Cancer · 被引 6)